Cargando…

An iridium(iii)-based irreversible protein–protein interaction inhibitor of BRD4 as a potent anticancer agent

Bromodomain-containing protein 4 (BRD4) has recently emerged as an attractive epigenetic target for anticancer therapy. In this study, an iridium(iii) complex is reported as the first metal-based, irreversible inhibitor of BRD4. Complex 1a is able to antagonize the BRD4-acetylated histone protein–pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhong, Hai-Jing, Lu, Lihua, Leung, Ka-Ho, Wong, Catherine C. L., Peng, Chao, Yan, Siu-Cheong, Ma, Dik-Lung, Cai, Zongwei, David Wang, Hui-Min, Leung, Chung-Hang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Royal Society of Chemistry 2015
Materias:	Chemistry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5510529/ https://www.ncbi.nlm.nih.gov/pubmed/28757943 http://dx.doi.org/10.1039/c5sc02321a

Ejemplares similares

Luminescent chemosensors by using cyclometalated iridium(iii) complexes and their applications
por: Ma, Dik-Lung, et al.
Publicado: (2017)

Iridium(III) Complexes Targeting Apoptotic Cell Death in Cancer Cells
por: Ma, Dik-Lung, et al.
Publicado: (2019)

Development of a luminescent G-quadruplex-selective iridium(III) complex for the label-free detection of adenosine
por: Lu, Lihua, et al.
Publicado: (2016)

Inhibition of Beta-Amyloid Fibrillation by Luminescent Iridium(III) Complex Probes
por: Lu, Lihua, et al.
Publicado: (2015)

A colorimetric chemosensor for Cu(2+) ion detection based on an iridium(III) complex
por: Wang, Modi, et al.
Publicado: (2014)

Luminescent Iridium(III) Chemosensor for Tandem Detection of F(–) and Al(3+)
por: Liu, Jin-Biao, et al.
Publicado: (2017)

A Label-Free Luminescent Switch-On Assay for ATP Using a G-Quadruplex-Selective Iridium(III) Complex
por: Leung, Ka-Ho, et al.
Publicado: (2013)

Inhibition of the p53/hDM2 protein-protein interaction by cyclometallated iridium(III) compounds
por: Liu, Li-Juan, et al.
Publicado: (2016)

Identification of an iridium(III) complex with anti-bacterial and anti-cancer activity
por: Lu, Lihua, et al.
Publicado: (2015)

An Aldol Reaction-Based Iridium(III) Chemosensor for the Visualization of Proline in Living Cells
por: Liu, Jin-Biao, et al.
Publicado: (2016)

Luminescent turn-on detection of Hg(II) via the quenching of an iridium(III) complex by Hg(II)-mediated silver nanoparticles
por: Liu, Jinshui, et al.
Publicado: (2017)

Application of iridium(III) complex in label-free and non-enzymatic electrochemical detection of hydrogen peroxide based on a novel “on-off-on” switch platform
por: Miao, Xiangmin, et al.
Publicado: (2016)

A cyclometalated iridium(III) complex used as a conductor for the electrochemical sensing of IFN-γ
por: Miao, Xiangmin, et al.
Publicado: (2017)

Inhibition of the Ras/Raf interaction and repression of renal cancer xenografts in vivo by an enantiomeric iridium(iii) metal-based compound
por: Liu, Li-Juan, et al.
Publicado: (2017)

A Colorimetric and Luminescent Dual-Modal Assay for Cu(II) Ion Detection Using an Iridium(III) Complex
por: Ma, Dik-Lung, et al.
Publicado: (2014)

A long-lived peptide-conjugated iridium(iii) complex as a luminescent probe and inhibitor of the cell migration mediator, formyl peptide receptor 2
por: Vellaisamy, Kasipandi, et al.
Publicado: (2018)

A novel dinuclear iridium(III) complex as a G-quadruplex-selective probe for the luminescent switch-on detection of transcription factor HIF-1α
por: Lu, Lihua, et al.
Publicado: (2016)

Phosphorescent Imaging of Living Cells Using a Cyclometalated Iridium(III) Complex
por: Ma, Dik-Lung, et al.
Publicado: (2013)

Cell imaging of dopamine receptor using agonist labeling iridium(iii) complex
por: Vellaisamy, Kasipandi, et al.
Publicado: (2017)

Luminescent Iridium(III) Complexes Supported by N-Heterocyclic Carbene-based C^C^C-Pincer Ligands and Aromatic Diimines
por: Chung, Lai-Hon, et al.
Publicado: (2015)

A Highly Selective and Non-Reaction Based Chemosensor for the Detection of Hg(2+) Ions Using a Luminescent Iridium(III) Complex
por: Chan, Daniel Shiu-Hin, et al.
Publicado: (2013)

Turn-on Luminescent Probe for Hydrogen Peroxide Sensing and Imaging in Living Cells based on an Iridium(III) Complex–Silver Nanoparticle Platform
por: Liu, Jinshui, et al.
Publicado: (2017)

A bioactive ligand-conjugated iridium(III) metal-based complex as a Keap1–Nrf2 protein-protein interaction inhibitor against acetaminophen-induced acute liver injury
por: Li, Guodong, et al.
Publicado: (2021)

Ester-Modified Cyclometalated Iridium(III) Complexes as Mitochondria-Targeting Anticancer Agents
por: Wang, Fang-Xin, et al.
Publicado: (2016)

Ruthenium(II) and Iridium(III) Complexes as Tested Materials for New Anticancer Agents
por: Masternak, Joanna, et al.
Publicado: (2020)

Potent Half-Sandwich Iridium(III) Anticancer Complexes Containing C(∧)N-Chelated and Pyridine Ligands
por: Liu, Zhe, et al.
Publicado: (2014)

Iridium-based probe for luminescent nitric oxide monitoring in live cells
por: Wu, Chun, et al.
Publicado: (2018)

Cyclometalated iridium(iii) complexes as lysosome-targeted photodynamic anticancer and real-time tracking agents
por: He, Liang, et al.
Publicado: (2015)

Theranostic Lysosomal Targeting Anticancer and Antimetastatic Agents: Half-Sandwich Iridium(III) Rhodamine Complexes
por: Ma, Wenli, et al.
Publicado: (2019)

Potent anticancer activity of a novel iridium metallodrug via oncosis
por: Ortega-Forte, Enrique, et al.
Publicado: (2022)

Identification of an irreversible PPARγ antagonist with potent anticancer activity
por: Peng, Youyi, et al.
Publicado: (2020)

Discovery of a tetrahydroisoquinoline-based CDK9-cyclin T1 protein–protein interaction inhibitor as an anti-proliferative and anti-migration agent against triple-negative breast cancer cells
por: Cheng, Shasha, et al.
Publicado: (2021)

Anticancer osmium complex inhibitors of the HIF-1α and p300 protein-protein interaction
por: Yang, Chao, et al.
Publicado: (2017)

The Discovery of an Iridium(III) Dimer Complex as a Potent Antibacterial Agent against Non-Replicating Mycobacterium smegmatis
por: Liao, Guojian, et al.
Publicado: (2018)

Rational structural modification of the isatin scaffold to develop new and potent antimicrobial agents targeting bacterial peptidoglycan glycosyltransferase
por: Wang, Yong, et al.
Publicado: (2021)

Interaction between DNA, Albumin and Apo-Transferrin and Iridium(III) Complexes with Phosphines Derived from Fluoroquinolones as a Potent Anticancer Drug
por: Kozieł, Sandra Amanda, et al.
Publicado: (2021)

The design and development of covalent protein-protein interaction inhibitors for cancer treatment
por: Cheng, Sha-Sha, et al.
Publicado: (2020)

Correction to: The design and development of covalent protein-protein interaction inhibitors for cancer treatment
por: Cheng, Sha-Sha, et al.
Publicado: (2020)

Mimicking Strategy for Protein–Protein Interaction Inhibitor Discovery by Virtual Screening
por: Wu, Ke-Jia, et al.
Publicado: (2019)

Structure-Activity Relationship for Fe(III)-Salen-Like Complexes as Potent Anticancer Agents
por: Ghanbari, Zahra, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_g0ianmshikpu8v0jcmeulmidr9